Motivation after eXercise in Chronic Kidney Disease

INTERVENTION: Participants will be randomised to normal clinical care or a motivational intervention. The motivational intervention will be a face to face session lasting approximately 45 minutes. The session will utilise a number of behavioural change techniques such as motivational interviewing, goal setting and self‐monitoring. These patients will be followed up with supportive telephone calls at 2, 4 and 9 weeks and will have an approximately 10 minute face to face trouble shoot meeting at 6 weeks. CONDITION: Chronic Kidney Disease ; Urological and Genital Diseases PRIMARY OUTCOME: Endurance Shuttle Walk Test (ESWT) a measure of physical capacity or endurance fitness. This will be measured at 6 and 12 weeks. SECONDARY OUTCOME: 1. Quadriceps muscle size: 3D Ultrasonography. Measured at 6 weeks and 12 weeks ; 2. Physical function: Incremental shuttle walk test; sit to stand tests. Measured at 6 weeks and 12 weeks.; 3. Daily physical activity: 7 day accelerometry. Measured at 5 weeks and 11 weeks ; 4. Body composition: Weight, height, waist circumference. Measured at 6 weeks and 12 weeks; 5. Arterial stiffness: Pulse wave velocity. Measured at baseline, 6 weeks and 12 weeks; 6. Clinical parameters: Extracted from medical records. Measured at 6 weeks and 12 weeks; 7. Plasma markers of inflammation and oxidative stress, venous blood sample. Measured at 6 weeks and 12 weeks; 8. Quality of Life: SF36 and EQ5D questionnaires. Measured at 6 weeks and 12 weeks ; 9. Symptom perception: Chronic Kidney Disease Symptom Score. Measured at 6 weeks and 12 weeks ; 10. Physical Activity habits and attitudes: Leicester Kidney Patient Physical Activity Questionnaire (comprising Duke Activity Status Index; GP Physical Activity Questionnaire; Leisure Time Exercise Questionnaire; Stage of Change Questionnaire; Self Efficacy Questionnaire). Measured at 6 weeks, and 12 weeks ; 11. Fatigue: FACIT‐Fatigue Questionnaire & Visual Analogue Scale. Measured at baseline, 6 weeks, and 12 weeks ; 12. Appetite: Visual Analogue Scale. Measured at baseline, 6 weeks, 12 weeks, 18 weeks; 13. Health care usage: measured weekly; 14. Self‐reported physical activity and intensity: measured daily; 15: Patient satisfaction of intervention: measured at 12 weeks.; 16: Patient experiences of exercise intervention: explored during first 6 weeks; 17: Patient experiences of motivational intervention: explored at 12 weeks. INCLUSION CRITERIA: 1. Established chronic kidney disease (Stages 3b‐5) 2. Completed the ExTra CKD study protocol